BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/15/2018 4:16:45 AM | Browse: 899 | Download: 760
 |
Received |
|
2018-03-29 09:11 |
|
Peer-Review Started |
|
2018-03-29 09:50 |
|
To Make the First Decision |
|
2018-04-23 05:46 |
|
Return for Revision |
|
2018-04-24 05:16 |
|
Revised |
|
2018-04-26 18:42 |
|
Second Decision |
|
2018-06-12 09:31 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-06-14 05:49 |
|
Articles in Press |
|
2018-06-14 05:49 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-06-18 00:43 |
|
Typeset the Manuscript |
|
2018-07-07 06:57 |
|
Publish the Manuscript Online |
|
2018-07-15 04:16 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
Role of bisphosphonates in the management of acute Charcot foot
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Harsh Durgia, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Rajan Palui, Kalyani Sridharan and Henith Raj |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jayaprakash Sahoo, Associate Professor, Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Room No. 5444, 4th floor, Superspeciality Block, Pondicherry 605006, India. jppgi@yahoo.com |
| Key Words |
Charcot foot; Diabetes mellitus; Charcot neuroarthropathy; Bisphosphonates; Pamidronate |
| Core Tip |
Bisphosphonate is an attractive treatment option for acute Charcot foot. This is based on the fact that increased osteoclastic activity plays a central role in the pathogenesis of acute Charcot foot. Among bisphosphonates, the maximum evidence in the literature is available for pamidronate. It has been shown to reduce the markers of Charcot foot activity, like raised skin temperature, pain, and edema. However, the quality of evidence is low. They should be used along with immobilization and offloading. The side effects of bisphosphonates and their contra-indications for use should be kept in mind while treating these patients with them. |
| Publish Date |
2018-07-15 04:16 |
| Citation |
Durgia H, Sahoo J, Kamalanathan S, Palui R, Sridharan K, Raj H. Role of bisphosphonates in the management of acute Charcot foot. World J Diabetes 2018; 9(7): 115-126 |
| URL |
http://www.wjgnet.com/1948-9358/full/v9/i7/115.htm |
| DOI |
http://dx.doi.org/10.4239/wjd.v9.i7.115 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
